Pulmonary Functions Testing systems Market Overview

The Global Pulmonary Function Testing Systems market was valued at USD 2.55 billion in 2021 and is expected to reach USD 4.08 billion by the year 2028, at a CAGR of 6.93%

Pulmonary Functions Testing systems are non-invasive tests that are used to detect how well an individual’s lungs are working. Pulmonary Functions Testing system comprise of series of tests that are used for detecting if there is an infection in the lungs that are fatal. They also determine and measure the effectiveness of pulmonary inhalation and exhalation functions. These tests are used to detect certain types of lung diseases such as asthma, bronchitis, and shortness of breath.

Market Growth

The major driving factors for the Pulmonary Functions Testing systems are the increasing chronic lung diseases and lung cancer. According to the report of the American Cancer Society in 2019, in the United States, around 228,150 new cases for lung cancer were registered. Also, it was recorded that around 142,670 deaths occurred in the United States due to lung cancer. The increasing demand for minimal tests and research & development to design an effective method or test for treating lung disease is also propelling the growth of Pulmonary Functions Testing systems market.

By the end of 2027, the Pulmonary Functions Testing systems market size is estimated to be USD 3811.21 million. The increasing awareness about health is also a driving factor for the growth of the market. The high demand from the end-user industry is expected to increase the growth of Pulmonary Functions Testing system market in the forecast period.

The Pulmonary Functions Testing systems market is segmented by Type (Complete PFT Systems and Portable PFT Systems), By Test Type (Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test and High Altitude Simulation Testing), By Component (Software, Hardware and Services), by Application (Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath and Restrictive Lung Disease), by End-User (Hospital/Clinical Laboratories and Diagnostics Laboratories). Pulmonary Functions Test system market is further analyzed on the basis of regional analysis and divided into major regions like North-America, Latin America, Asia-Pacific, Europe and MEA.

Impact of COVID-19 on Pulmonary Functions Testing systems Market

The emergence of covid-19 affected a lot of people’s immunity and health, especially the respiratory system. The effect of coronavirus people affected an individual’s lungs a lot which needed a lot of Pulmonary Functions Testing system for the detection. Hence the impact of coronavirus was a bit positive on the market due to the high demand for these tests from medical practitioners. Further analysis on Covid-19 impact on the Pulmonary Functions Test systems market is done in the IMR market research report.  

Market Segmentation

Application Insights:

By application type, Pulmonary Functions Testing system market is segmented into Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, and Restrictive Lung Disease. In this segment, Restrictive Lung Disease is accounted for the largest segment with more than half of Pulmonary Functions Testing system market share of 45.77% and estimated to have a market size of USD 1619.73 million in the year 2026 with the CAGR of 6.87%. While the segment for Chronic Shortness of Breath is expected to have the highest CAGR of 6.90% in the forecast period and Pulmonary Functions Testing system market size of USD 722.16 million in the year 2026.

Test Type Insights:

By Test Type, the Pulmonary Functions Testing system market is segmented into Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, and High-Altitude Simulation Testing. In this segment, the Spirometry segment is accounted for the largest segment with a market share of 34.32% and estimated to have a Pulmonary Functions Testing system market size of USD 1211.75 million in the year 2026 with a CAGR of 6.84%. 

Major Key Players Considered in the Market

Salient Features of the Pulmonary Functions Testing systems Market

The Global Pulmonary Function Testing Systems market was valued at USD 2.55 billion in 2021 and is expected to reach USD 4.08 billion by the year 2028, at a CAGR of 6.93%

  • The need for regular pulmonary check-ups of people of all age groups has given a boost to the growth of the market for Pulmonary Functions Testing system and has created recent opportunities for market players.
  • Excessive consumption of cigarette smoking has increased the number of people suffering from lung cancer which is a driving factor for Pulmonary Functions Testing system market growth.
  • The growing geriatric population and the increasing population due to the urbanization of the countries have also played a major role in the mushrooming growth of the market for Pulmonary Functions Testing systems.

Global Pulmonary Function Testing Systems Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 2.55 Bn.

Forecast Period 2022-28 CAGR:

6.93%

Market Size in 2028:

USD 4.08 Bn.

Segments Covered:

By Type

  • Complete PFT Systems
  • Portable PFT Systems

By Test Type

  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • High Altitude Simulation Testing

By Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Chronic Lung Diseases and Lung Cancer

Key Market Restraints:

  • High Cost of Raw Material for Manufacturing or Assembling the Testing Equipment

Key Opportunities:

  • High Penetration of New Technology in Healthcare Infrastructure

Companies Covered in the report:

  • BD, MGC Diagnostic, Data Sciences International, Medline Industries, Ganshorn, and other major players.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Test Type
 3.3 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Pulmonary Function Testing Systems Market by Type
 5.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 5.2 Pulmonary Function Testing Systems Market Overview
 5.3 Complete PFT Systems
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Complete PFT Systems: Grographic Segmentation
 5.4 Portable PFT Systems
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Portable PFT Systems: Grographic Segmentation

Chapter 6: Pulmonary Function Testing Systems Market by Test Type
 6.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 6.2 Pulmonary Function Testing Systems Market Overview
 6.3 Spirometry
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Spirometry: Grographic Segmentation
 6.4 Lung Volume
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Lung Volume: Grographic Segmentation
 6.5 Gas Exchange Testing
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Gas Exchange Testing: Grographic Segmentation
 6.6 Maximal Voluntary Ventilation
  6.6.1 Introduction and Market Overview
  6.6.2 Historic and Forecasted Market Size (2016-2028F)
  6.6.3 Key Market Trends, Growth Factors and Opportunities
  6.6.4 Maximal Voluntary Ventilation: Grographic Segmentation
 6.7 Oxygen Titration Test
  6.7.1 Introduction and Market Overview
  6.7.2 Historic and Forecasted Market Size (2016-2028F)
  6.7.3 Key Market Trends, Growth Factors and Opportunities
  6.7.4 Oxygen Titration Test: Grographic Segmentation
 6.8 High Altitude Simulation Testing
  6.8.1 Introduction and Market Overview
  6.8.2 Historic and Forecasted Market Size (2016-2028F)
  6.8.3 Key Market Trends, Growth Factors and Opportunities
  6.8.4 High Altitude Simulation Testing: Grographic Segmentation

Chapter 7: Pulmonary Function Testing Systems Market by Application
 7.1 Pulmonary Function Testing Systems Market Overview Snapshot and Growth Engine
 7.2 Pulmonary Function Testing Systems Market Overview
 7.3 Chronic Obstructive Pulmonary Disease
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Chronic Obstructive Pulmonary Disease: Grographic Segmentation
 7.4 Asthma
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Asthma: Grographic Segmentation
 7.5 Chronic Shortness of Breath
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Chronic Shortness of Breath: Grographic Segmentation
 7.6 Restrictive Lung Disease
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Restrictive Lung Disease: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Pulmonary Function Testing Systems Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Pulmonary Function Testing Systems Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Pulmonary Function Testing Systems Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 CAREFUSION (BD)
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 MGC DIAGNOSTIC
 8.4 DATA SCIENCES INTERNATIONAL
 8.5 MEDLINE INDUSTRIES
 8.6 GANSHORN
 8.7 3M
 8.8 NSPIRE HEALTH
 8.9 SCHILLER
 8.10 MORGAN SCIENTIFIC
 8.11 CHEST
 8.12 NDD
 8.13 VYAIRE MEDICAL
 8.14 COSMED
 8.15 OTHER MAJOR PLAYERS

Chapter 9: Global Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Complete PFT Systems
  9.2.2 Portable PFT Systems
 9.3 Historic and Forecasted Market Size By Test Type
  9.3.1 Spirometry
  9.3.2 Lung Volume
  9.3.3 Gas Exchange Testing
  9.3.4 Maximal Voluntary Ventilation
  9.3.5 Oxygen Titration Test
  9.3.6 High Altitude Simulation Testing
 9.4 Historic and Forecasted Market Size By Application
  9.4.1 Chronic Obstructive Pulmonary Disease
  9.4.2 Asthma
  9.4.3 Chronic Shortness of Breath
  9.4.4 Restrictive Lung Disease

Chapter 10: North America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Complete PFT Systems
  10.4.2 Portable PFT Systems
 10.5 Historic and Forecasted Market Size By Test Type
  10.5.1 Spirometry
  10.5.2 Lung Volume
  10.5.3 Gas Exchange Testing
  10.5.4 Maximal Voluntary Ventilation
  10.5.5 Oxygen Titration Test
  10.5.6 High Altitude Simulation Testing
 10.6 Historic and Forecasted Market Size By Application
  10.6.1 Chronic Obstructive Pulmonary Disease
  10.6.2 Asthma
  10.6.3 Chronic Shortness of Breath
  10.6.4 Restrictive Lung Disease
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Complete PFT Systems
  11.4.2 Portable PFT Systems
 11.5 Historic and Forecasted Market Size By Test Type
  11.5.1 Spirometry
  11.5.2 Lung Volume
  11.5.3 Gas Exchange Testing
  11.5.4 Maximal Voluntary Ventilation
  11.5.5 Oxygen Titration Test
  11.5.6 High Altitude Simulation Testing
 11.6 Historic and Forecasted Market Size By Application
  11.6.1 Chronic Obstructive Pulmonary Disease
  11.6.2 Asthma
  11.6.3 Chronic Shortness of Breath
  11.6.4 Restrictive Lung Disease
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Complete PFT Systems
  12.4.2 Portable PFT Systems
 12.5 Historic and Forecasted Market Size By Test Type
  12.5.1 Spirometry
  12.5.2 Lung Volume
  12.5.3 Gas Exchange Testing
  12.5.4 Maximal Voluntary Ventilation
  12.5.5 Oxygen Titration Test
  12.5.6 High Altitude Simulation Testing
 12.6 Historic and Forecasted Market Size By Application
  12.6.1 Chronic Obstructive Pulmonary Disease
  12.6.2 Asthma
  12.6.3 Chronic Shortness of Breath
  12.6.4 Restrictive Lung Disease
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Complete PFT Systems
  13.4.2 Portable PFT Systems
 13.5 Historic and Forecasted Market Size By Test Type
  13.5.1 Spirometry
  13.5.2 Lung Volume
  13.5.3 Gas Exchange Testing
  13.5.4 Maximal Voluntary Ventilation
  13.5.5 Oxygen Titration Test
  13.5.6 High Altitude Simulation Testing
 13.6 Historic and Forecasted Market Size By Application
  13.6.1 Chronic Obstructive Pulmonary Disease
  13.6.2 Asthma
  13.6.3 Chronic Shortness of Breath
  13.6.4 Restrictive Lung Disease
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Pulmonary Function Testing Systems Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Complete PFT Systems
  14.4.2 Portable PFT Systems
 14.5 Historic and Forecasted Market Size By Test Type
  14.5.1 Spirometry
  14.5.2 Lung Volume
  14.5.3 Gas Exchange Testing
  14.5.4 Maximal Voluntary Ventilation
  14.5.5 Oxygen Titration Test
  14.5.6 High Altitude Simulation Testing
 14.6 Historic and Forecasted Market Size By Application
  14.6.1 Chronic Obstructive Pulmonary Disease
  14.6.2 Asthma
  14.6.3 Chronic Shortness of Breath
  14.6.4 Restrictive Lung Disease
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Global Pulmonary Function Testing Systems Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 2.55 Bn.

Forecast Period 2022-28 CAGR:

6.93%

Market Size in 2028:

USD 4.08 Bn.

Segments Covered:

By Type

  • Complete PFT Systems
  • Portable PFT Systems

By Test Type

  • Spirometry
  • Lung Volume
  • Gas Exchange Testing
  • Maximal Voluntary Ventilation
  • Oxygen Titration Test
  • High Altitude Simulation Testing

By Application

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Chronic Shortness of Breath
  • Restrictive Lung Disease

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Chronic Lung Diseases and Lung Cancer

Key Market Restraints:

  • High Cost of Raw Material for Manufacturing or Assembling the Testing Equipment

Key Opportunities:

  • High Penetration of New Technology in Healthcare Infrastructure

Companies Covered in the report:

  • BD, MGC Diagnostic, Data Sciences International, Medline Industries, Ganshorn, and other major players.

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. PULMONARY FUNCTION TESTING SYSTEMS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. PULMONARY FUNCTION TESTING SYSTEMS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. PULMONARY FUNCTION TESTING SYSTEMS MARKET COMPETITIVE RIVALRY
TABLE 005. PULMONARY FUNCTION TESTING SYSTEMS MARKET THREAT OF NEW ENTRANTS
TABLE 006. PULMONARY FUNCTION TESTING SYSTEMS MARKET THREAT OF SUBSTITUTES
TABLE 007. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY TYPE
TABLE 008. COMPLETE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. PORTABLE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 010. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY TEST TYPE
TABLE 011. SPIROMETRY MARKET OVERVIEW (2016-2028)
TABLE 012. LUNG VOLUME MARKET OVERVIEW (2016-2028)
TABLE 013. GAS EXCHANGE TESTING MARKET OVERVIEW (2016-2028)
TABLE 014. MAXIMAL VOLUNTARY VENTILATION MARKET OVERVIEW (2016-2028)
TABLE 015. OXYGEN TITRATION TEST MARKET OVERVIEW (2016-2028)
TABLE 016. HIGH ALTITUDE SIMULATION TESTING MARKET OVERVIEW (2016-2028)
TABLE 017. PULMONARY FUNCTION TESTING SYSTEMS MARKET BY APPLICATION
TABLE 018. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
TABLE 019. ASTHMA MARKET OVERVIEW (2016-2028)
TABLE 020. CHRONIC SHORTNESS OF BREATH MARKET OVERVIEW (2016-2028)
TABLE 021. RESTRICTIVE LUNG DISEASE MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST TYPE (2016-2028)
TABLE 024. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 025. N PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 027. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST TYPE (2016-2028)
TABLE 028. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 029. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 031. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST TYPE (2016-2028)
TABLE 032. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 033. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 037. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TYPE (2016-2028)
TABLE 039. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY TEST TYPE (2016-2028)
TABLE 040. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY APPLICATION (2016-2028)
TABLE 041. PULMONARY FUNCTION TESTING SYSTEMS MARKET, BY COUNTRY (2016-2028)
TABLE 042. CAREFUSION (BD): SNAPSHOT
TABLE 043. CAREFUSION (BD): BUSINESS PERFORMANCE
TABLE 044. CAREFUSION (BD): PRODUCT PORTFOLIO
TABLE 045. CAREFUSION (BD): KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. MGC DIAGNOSTIC: SNAPSHOT
TABLE 046. MGC DIAGNOSTIC: BUSINESS PERFORMANCE
TABLE 047. MGC DIAGNOSTIC: PRODUCT PORTFOLIO
TABLE 048. MGC DIAGNOSTIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. DATA SCIENCES INTERNATIONAL: SNAPSHOT
TABLE 049. DATA SCIENCES INTERNATIONAL: BUSINESS PERFORMANCE
TABLE 050. DATA SCIENCES INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 051. DATA SCIENCES INTERNATIONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. MEDLINE INDUSTRIES: SNAPSHOT
TABLE 052. MEDLINE INDUSTRIES: BUSINESS PERFORMANCE
TABLE 053. MEDLINE INDUSTRIES: PRODUCT PORTFOLIO
TABLE 054. MEDLINE INDUSTRIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. GANSHORN: SNAPSHOT
TABLE 055. GANSHORN: BUSINESS PERFORMANCE
TABLE 056. GANSHORN: PRODUCT PORTFOLIO
TABLE 057. GANSHORN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. 3M: SNAPSHOT
TABLE 058. 3M: BUSINESS PERFORMANCE
TABLE 059. 3M: PRODUCT PORTFOLIO
TABLE 060. 3M: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. NSPIRE HEALTH: SNAPSHOT
TABLE 061. NSPIRE HEALTH: BUSINESS PERFORMANCE
TABLE 062. NSPIRE HEALTH: PRODUCT PORTFOLIO
TABLE 063. NSPIRE HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. SCHILLER: SNAPSHOT
TABLE 064. SCHILLER: BUSINESS PERFORMANCE
TABLE 065. SCHILLER: PRODUCT PORTFOLIO
TABLE 066. SCHILLER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. MORGAN SCIENTIFIC: SNAPSHOT
TABLE 067. MORGAN SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 068. MORGAN SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 069. MORGAN SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. CHEST: SNAPSHOT
TABLE 070. CHEST: BUSINESS PERFORMANCE
TABLE 071. CHEST: PRODUCT PORTFOLIO
TABLE 072. CHEST: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. NDD: SNAPSHOT
TABLE 073. NDD: BUSINESS PERFORMANCE
TABLE 074. NDD: PRODUCT PORTFOLIO
TABLE 075. NDD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. VYAIRE MEDICAL: SNAPSHOT
TABLE 076. VYAIRE MEDICAL: BUSINESS PERFORMANCE
TABLE 077. VYAIRE MEDICAL: PRODUCT PORTFOLIO
TABLE 078. VYAIRE MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. COSMED: SNAPSHOT
TABLE 079. COSMED: BUSINESS PERFORMANCE
TABLE 080. COSMED: PRODUCT PORTFOLIO
TABLE 081. COSMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 082. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 083. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 084. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY TYPE
FIGURE 012. COMPLETE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. PORTABLE PFT SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 014. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY TEST TYPE
FIGURE 015. SPIROMETRY MARKET OVERVIEW (2016-2028)
FIGURE 016. LUNG VOLUME MARKET OVERVIEW (2016-2028)
FIGURE 017. GAS EXCHANGE TESTING MARKET OVERVIEW (2016-2028)
FIGURE 018. MAXIMAL VOLUNTARY VENTILATION MARKET OVERVIEW (2016-2028)
FIGURE 019. OXYGEN TITRATION TEST MARKET OVERVIEW (2016-2028)
FIGURE 020. HIGH ALTITUDE SIMULATION TESTING MARKET OVERVIEW (2016-2028)
FIGURE 021. PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY APPLICATION
FIGURE 022. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 023. ASTHMA MARKET OVERVIEW (2016-2028)
FIGURE 024. CHRONIC SHORTNESS OF BREATH MARKET OVERVIEW (2016-2028)
FIGURE 025. RESTRICTIVE LUNG DISEASE MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA PULMONARY FUNCTION TESTING SYSTEMS MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Pulmonary Function Testing Systems Market research report?

The forecast period in the Pulmonary Function Testing Systems Market research report is 2022-2028.

Who are the key players in Pulmonary Function Testing Systems Market?

CareFusion (BD), MGC Diagnostic, Data Sciences International, Medline Industries, Ganshorn, and other major players.

What are the segments of the Pulmonary Function Testing Systems Market?

The Pulmonary Function Testing Systems Market is segmented into Type, Test Type, Application, and region. By Type, the market is categorized into Complete PFT Systems and Portable PFT Systems. By Test Type, the market is categorized into Spirometry, Lung Volume, Gas Exchange Testing, Maximal Voluntary Ventilation, Oxygen Titration Test, and High-Altitude Simulation Testing. By Application, the market is categorized into Chronic Obstructive Pulmonary Disease, Asthma, Chronic Shortness of Breath, and Restrictive Lung Disease. By region, it is analyzed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Pulmonary Function Testing Systems Market?

Pulmonary Functions Test systems are non-invasive tests that are used to detect how well an individual’s lungs are working. The pulmonary Functions Test system comprises of series of tests that are used for detecting if there is an infection in the lungs that are fatal. They also determine and measure the effectiveness of pulmonary inhalation and exhalation functions. These tests are used to detect certain types of lung diseases such as asthma, bronchitis, and shortness of breath.

How big is the Pulmonary Function Testing Systems Market?

The Global Pulmonary Function Testing Systems market was valued at USD 2.55 billion in 2021 and is expected to reach USD 4.08 billion by the year 2028, at a CAGR of 6.93%